Schedule 13D ownership disclosure
CELLECT BIOTECHNOLOGY LTD
Security class unavailable · CUSIP: 15116C102
Event date: 2019-02-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 16.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-19-002921
- Form type
- SC 13D
- Filer
- Quoin Pharmaceuticals, Ltd.
- CIK
- CIK 1671502
- Filed
- Feb 20, 2019
- Reporting period
- Feb 12, 2019
- Description
- Schedule 13D beneficial ownership